BeStock  
Stocks › Biotechnology › LTGO

Latigo Biotherapeutics LTGO

US equityMarket cap rank #3257Biotechnology
$13.00 −$0.24 (-1.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.00 0.00%
Open$13.22
Prev close$13.24
Day range$11.91 – $13.35
Volume267.2K
Market cap$861.89M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.1x
CheapRich

Near the top of its 5-year range · 89th percentile, 5-year average -10.0x

Price / book2.2x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average -3.7x

#3263 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-15x-10x-4x1xAug '26Sep '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$14.63
Price vs. fair value-11.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.21 – -3.69 96% (pricier than usual) #3263 of 5329 (1 = cheapest)
PE -8.10 -6.41 -10.01 89% (pricier than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on LTGO.

Sign in to join the discussion.

Scroll to Top